Neurocrine Biosciences
NBIX
#1553
Rank
NZ$19.92 B
Marketcap
$199.87
Share price
-0.01%
Change (1 day)
-7.54%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company